These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31119725)

  • 21. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey.
    Chollat C; Le Doussal L; de la Villéon G; Provost D; Marret S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):304. PubMed ID: 28903747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital.
    Pang J
    N Z Med J; 2017 Jul; 130(1458):52-53. PubMed ID: 28694540
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births].
    Wolf HT; Hegaard HK; Huusom L; Greisen G; Hedegaard M
    Ugeskr Laeger; 2011 Mar; 173(13):962-5. PubMed ID: 21453636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.
    Crowther CA; Ashwood P; Middleton PF; McPhee A; Tran T; Harding JE;
    JAMA; 2023 Aug; 330(7):603-614. PubMed ID: 37581672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis.
    Bickford CD; Magee LA; Mitton C; Kruse M; Synnes AR; Sawchuck D; Basso M; Senikas VM; von Dadelszen P;
    BMC Health Serv Res; 2013 Dec; 13():527. PubMed ID: 24350635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal Corticosteroids and Magnesium Sulfate for Improved Preterm Neonatal Outcomes: A Review of Guidelines.
    Tsakiridis I; Mamopoulos A; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2020 May; 75(5):298-307. PubMed ID: 32469415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of brain development by antenatal magnesium sulphate for infants born preterm.
    Chollat C; Sentilhes L; Marret S
    Dev Med Child Neurol; 2019 Jan; 61(1):25-30. PubMed ID: 30294845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
    Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
    BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 33. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
    Obstet Gynecol; 2010 Mar; 115(3):669-671. PubMed ID: 20177305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium sulphate for women at term for neuroprotection of the fetus.
    Nguyen TM; Crowther CA; Wilkinson D; Bain E
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
    McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
    Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gynecology/Obstetrics. Magnesium sulfate for fetal neuroprotection in preterm delivery. Latest advances in contraception.].
    Irion O; Julen O; Dubuisson JB; Yaron M; Lourenço AG
    Rev Med Suisse; 2011 Jan; 7(278):117-20. PubMed ID: 21400942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preterm labor: approach to decreasing complications of prematurity.
    Locatelli A; Consonni S; Ghidini A
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection].
    Lloreda-Garcia JM; Lorente-Nicolás A; Bermejo-Costa F; Martínez-Uriarte J; López-Pérez R
    Rev Chil Pediatr; 2016; 87(4):261-7. PubMed ID: 26778008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.